iShares Russell Top 200

Most Recent

  • uploads///Chart  Neuro
    Earnings Report

    Eli Lilly’s 1Q17 Earnings: Strattera and Other Neuroscience Products

    Strattera, a drug for attention-deficit hyperactivity disorder, reported a 4% increase in revenues to $196.2 million in 1Q17, compared to $188.1 million in 1Q16.

    By Mike Benson
  • uploads///Part  Graph
    Basic Materials

    How Did DuPont’s Performance Materials Segment Perform in 2Q16?

    For 2Q16, DuPont’s Performance Materials segment reported revenue of $1.33 billion, representing 18.9% of DuPont’s total revenue.

    By Peter Neil
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.